cover
Contact Name
Helmina Wati
Contact Email
kontak.stikesbl@gmail.com
Phone
+6287814594045
Journal Mail Official
borneojournalofpharmascientech@gmail.com
Editorial Address
Jalan Kelapa Sawit 8 Bumi Berkat, Sungai Besar, Banjarbaru Utara, Kota Banjarbaru, Kalimantan Selatan
Location
Kota banjarbaru,
Kalimantan selatan
INDONESIA
Borneo Journal Of Pharmascientech
ISSN : 25413651     EISSN : 25483897     DOI : -
Core Subject : Health, Science,
Borneo Journal of Pharmascientech merupakan jurnal resmi Sekolah Tinggi Ilmu Kesehatan Borneo Lestari. Jurnal memuat naskah hasil penelitian dan artikel review bidang kefarmasian, meliputi farmasi klinik, manajemen & farmasi sosial, farmasi bahan alam, teknologi sediaan farmasi dan lain-lain. Naskah dapat berasal dari mahasiswa, dosen, peneliti, dan lembaga riset.
Articles 213 Documents
Analisis Reaksi Obat Tidak Diinginkan Yang Terkait Dengan Interaksi Obat Pada Pasien Yang Dirawat Dengan Amlodipin Amelia Rumi; Andi Atirah Masyita; Muhammad Rinaldhi Tandah; Inggrid Alvionita H. Lagoa; Abdurrahman Hasymi; Ratih Pratiwi Sari
BORNEO JOURNAL OF PHARMASCIENTECH Vol 10 No 2 (2026): Borneo Journal Of Pharmascientech
Publisher : Universitas Borneo Lestari

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.59053/bjp.v10i2.830

Abstract

Drug interactions may cause adverse drug reactions (ADRs), particularly in patients with hypertension and comorbidities who receive multiple medications concomitantly. This study aimed to identify suspected ADRs associated with drug interactions in patients receiving amlodipine and to assess causality using the Naranjo Algorithm. This was a descriptive study with a cross-sectional design and a prospective approach conducted among patients with hypertension at a hospital in Palu, Indonesia, from October to December 2023. Data were collected through patient interviews and medical record reviews, analyzed descriptively, and assessed using the Naranjo Algorithm. Among the 50 patients studied, four (8%) experienced suspected ADRs associated with the concomitant use of amlodipine and other medications. Three of the 39 patients receiving simvastatin (7.69%) reported muscle pain and weakness, whereas one of the eight patients receiving metformin (12.50%) experienced hypoglycemia, with a random blood glucose level of 37 mg/dL. The Naranjo Algorithm yielded a score of +5 for the cases involving simvastatin and +6 for the case involving metformin, both of which were classified as probable. These findings highlight the importance of clinical monitoring and medication review in patients receiving amlodipine concomitantly with other medications. However, the causal relationship between the drug interactions and the observed clinical manifestations should be interpreted cautiously.
Formulasi dan Evaluasi Sediaan Masker Gel Peel Off Ekstrak Etanol 96% Daun Rambusa (Passiflora Foetida L.) Destya Cahyani; Fairuz Yaumil Afra; Abdurrahman
BORNEO JOURNAL OF PHARMASCIENTECH Vol 10 No 2 (2026): Borneo Journal Of Pharmascientech
Publisher : Universitas Borneo Lestari

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.59053/bjp.v10i2.867

Abstract

The 96% ethanol extract of rambusa leaves (Passiflora foetida L.) exhibited a potent antioxidant activity with an IC50 value of 93.269 µg/mL, qualifying it as a suitable active ingredient for cosmetic preparations, such as a peel off gel mask. The key components influencing the mask characteristics are the gelling agent and the film forming agent, where their type and concentration significantly affect the stability and physical properties of the formulation. This study aimed to determine the effect of different types and concentrations of gelling and film-forming agents on the evaluation results of the rambusa leaf ethanol extract peel off gel mask preparation, observed through stability testing, to obtain an optimal formula. The rambusa leaves extract was obtained using the maceration method with 96% ethanol as the solvent. Six gel formulas were prepared with variations in the type and concentration of gelling and film-forming agents: F1 (PVA 10%), F2 (PVA 12%), F3 (HPMC 2.5%), F4 (HPMC 3%), F5 (PVA 14%, HPMC 3%), and F6 (PVA 16%, HPMC 4%). The evaluation included organoleptic tests, homogeneity tests, spreadability tests, adhesiveness tests, drying time tests, pH tests, viscosity tests, stability tests, then analyzed statistically using One-Way ANOVA. The results of the physical evaluation of F1-F6 showed that the preparations had stable homogeneity. Preparations with high concentrations will increase viscosity which makes the spreadability decrease but the adhesiveness will be longer. Formulas with PVA bases have a faster drying time than HPMC. The resulting pH is stable on all F1-F6 bases. It can be concluded that differences in the type and concentration of gelling agents can affect the results of organoleptic evaluation, spreadability, adhesiveness, drying time, viscosity, and stability of the preparation both before and after stability. The optimal formula obtained was F2 because it had good homogeneity, spreadability, adhesiveness, drying time, pH, viscosity, and stability. F3-F4 obtained the hedonic category with the highest percentage, namely 89% (very like).
Analisis Faktor Prediktor Potensi Interaksi Obat Pada Pasien Tuberkulosis Paru Di Rsd Idaman Banjarbaru Rifqy Koeswandi; Herningtyas Nautika Lingga; Satrio Wibowo Rahmatullah
BORNEO JOURNAL OF PHARMASCIENTECH Vol 10 No 2 (2026): Borneo Journal Of Pharmascientech
Publisher : Universitas Borneo Lestari

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.59053/bjp.v10i2.871

Abstract

Penggunaan bersama beberapa obat pada pasien tuberkulosis (TB) paru dapat meningkatkan potensi terjadinya interaksi obat yang dapat mempengaruhi keamanan dan efektivitas obat. Penelitian ini dilakukan bertujuan menganalisis potensi interaksi obat dan faktor prediktor yang berhubungan dengan potensi interaksi obat pada pasien TB paru di RSD Idaman Banjarbaru. Penelitian ini berupa observasional non-eksperimental dengan pendekatan deskriptif dan pengumpulan data retrospektif dilakukan terhadap 86 pasien TB paru tahun 2023. Potensi interaksi obat diidentifikasi menggunakan Lexicomp, sedangkan faktor prediktor dianalisis menggunakan regresi logistik biner. Potensi interaksi obat ditemukan pada 80 pasien (93,0%), dengan 167 kejadian interaksi dari 46 kombinasi obat. Sebagian besar interaksi bersifat farmakokinetik (80,8%), memiliki tingkat keparahan moderat (79,0%), dan termasuk kategori risiko C (79,0%). Jumlah obat merupakan faktor prediktor yang signifikan terhadap potensi interaksi obat (p = 0,020; OR = 13,562). Pasien yang menerima ≥5 obat berpotensi terjadi interaksi obat 13,562 kali dibandingkan pasien yang menerima 2–4 obat. Potensi interaksi obat ditemukan pada sebagian besar pasien TB paru, dengan jumlah obat sebagai faktor prediktor yang signifikan.